Pages

Wednesday, September 23, 2009

DCA

2 years ago, the University of Alberta started a clinical trial of a drug called DCA. This drug sparked their interest after killing a few types of Cancer in test tubes, then later in mice. Dr Michelakis is spearheading this trial and people have been anxiously waiting for the results of the study for more then 2 years now, but the results are on hold until the complete study is finished and published. No word has come out as to how much longer it would take. As far as the pharmaceutical companies are concerned DCA is worthless to them because it has no exclusivity, meaning they cannot make money from it. It just goes to show the fact that these companies care only about money. Some people have taken things into their own hands and buying DCA in bulk since some DCA manufacturers sell it, but it is meant for rare disorders. It is not recommended you do this but if you do find out as much as you can before you take a giant blind leap. This forum could be helpful www.thedcasite.com Educate yourself!

No comments:

Post a Comment